Neuromed strikes major Merck deal
Article Abstract:
Neuromed Pharmaceuticals Ltd. a spin off of British Columbia University has struck a drug research deal valued at up to $500 million (U.S) with giant Merck &Co. Inc., the biggest collaboration in Canada. Details of the deal are presented.
Publication Name: Globe & Mail (Toronto, Canada)
Subject: News, opinion and commentary
ISSN: 0319-0714
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
Generic drug makers target new proposal
Article Abstract:
The new food and drug regulation-eight year data protection for brand names, adopted by the federal government of Canada is opposed by the generic drug makers as it would hamper the efforts of the generic drug makers.
Publication Name: Globe & Mail (Toronto, Canada)
Subject: News, opinion and commentary
ISSN: 0319-0714
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
Does toxic fish hold medical marvels?
Article Abstract:
The details on the testing of tetrodotoxin drug by Wex Pharmaceuticals Inc. to solve chronic pain in central nervous system are examined.
Publication Name: Globe & Mail (Toronto, Canada)
Subject: News, opinion and commentary
ISSN: 0319-0714
Year: 2005
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Firms cautious over hot quarter. Ottawa open to China in small doses. A year after Fiorina's exit, Hurd makes his mark at HP
- Abstracts: Montreal port head lauds CP Ships deal. British firm snaps up Canadian itravel2000
- Abstracts: CanWest serves notice it plans to sever ties with the Canadian Press. CanWest spinoff could net the firm about $770-million
- Abstracts: 'Warning shot' on trusts set for budget. OECD warns hot economy could tip into overdrive. Confidence plummets to post-9/11 levels
- Abstracts: Legendary ad man French, sans cigar. Advertisers prepare to pull plug on hockey. CEO defends Tims U.S. push